Polycomb group proteins in cell cycle progression and cancer.
about
Molecular architecture of human polycomb repressive complex 2PHC3, a component of the hPRC-H complex, associates with E2F6 during G0 and is lost in osteosarcoma tumorsSuz12 is essential for mouse development and for EZH2 histone methyltransferase activityDimerization of a viral SET protein endows its functionNSPc1 is a cell growth regulator that acts as a transcriptional repressor of p21Waf1/Cip1 via the RARE elementThe Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cellsChromatin targeting drugs in cancer and immunityCoordinated regulation of transcriptional repression by the RBP2 H3K4 demethylase and Polycomb-Repressive Complex 2Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitionsThe polycomb repressive complex 2 is a potential target of SUMO modifications.Dietary omega-3 polyunsaturated fatty acids suppress expression of EZH2 in breast cancer cells.Transcription Factor Networks derived from Breast Cancer Stem Cells control the immune response in the Basal subtype.Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signalingSilencing of human polycomb target genes is associated with methylation of histone H3 Lys 27.Identification of driver and passenger DNA methylation in cancer by epigenomic analysis.Genome-wide identification of polycomb target genes reveals a functional association of Pho with Scm in Bombyx moriMutations in the extra sex combs and Enhancer of Polycomb genes increase homologous recombination in somatic cells of Drosophila melanogasterSilencing of Kruppel-like factor 2 by the histone methyltransferase EZH2 in human cancer.Uropathogenic E. coli (UPEC) Infection Induces Proliferation through Enhancer of Zeste Homologue 2 (EZH2).Wedelolactone disrupts the interaction of EZH2-EED complex and inhibits PRC2-dependent cancer.The ablation of EZH2 uncovers its crucial role in rhabdomyosarcoma formation.Inactivation of the polycomb group protein Ring1B unveils an antiproliferative role in hematopoietic cell expansion and cooperation with tumorigenesis associated with Ink4a deletion.Low BMI-1 expression is associated with an activated BMI-1-driven signature, vascular invasion, and hormone receptor loss in endometrial carcinoma.Genetic and epigenetic alterations in breast cancer: what are the perspectives for clinical practice?A multifactorial signature of DNA sequence and polycomb binding predicts aberrant CpG island methylationKnockdown BMI1 expression inhibits proliferation and invasion in human bladder cancer T24 cells.Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells.Curcumin analogue CDF inhibits pancreatic tumor growth by switching on suppressor microRNAs and attenuating EZH2 expressionEpigenetic regulation of miRNA-cancer stem cells nexus by nutraceuticals.MicroRNA-452 suppresses pancreatic cancer migration and invasion by directly targeting B-cell-specific Moloney murine leukemia virus insertion site 1.MicroRNA-128 coordinately targets Polycomb Repressor Complexes in glioma stem cells.Expression and Dendritic Trafficking of BDNF-6 Splice Variant are Impaired in Knock-In Mice Carrying Human BDNF Val66Met Polymorphism.Poly(ADP-ribose) Polymerase 1, PARP1, modifies EZH2 and inhibits EZH2 histone methyltransferase activity after DNA damage.Canonical PRC2 function is essential for mammary gland development and affects chromatin compaction in mammary organoids
P2860
Q21128799-86FBA247-02CE-4A3F-BA78-9CF8E52B1591Q24304471-04338A00-6DF1-487E-B420-B248087124DFQ24305075-37AA6B60-EFB4-4C5E-BD3F-40CE6408A129Q24615662-DBD2C59A-374F-42B2-AFD0-709604B9C3D5Q24674566-E0767E7C-D6AD-40C3-80F0-41215353D19DQ24680814-C214DE2B-4296-463F-A35B-E059C377181BQ26999888-7E2BFC2C-8E45-4933-8F35-2AAC47436FACQ28280326-8BA748B1-AC86-4153-83F4-268A8E357558Q29614512-53BAD32E-F8EA-4C86-B545-4E9BA40C98E6Q29871456-E8E83AFE-A3C0-4193-BE39-07A1E1343370Q33705232-9E380798-F516-4DCB-B20B-E7D5754D5BB3Q33767021-44CE745A-A475-4F83-B100-9330F49147A7Q33850652-A0977484-C728-447F-8CB2-5871BD34E4FEQ33979536-84CAC1D5-1ED2-4133-9D8B-D3ED79C1272FQ34181789-27C8B930-1278-4D93-B33B-2E3BEF91F4F3Q34224876-053E6B40-B226-428E-B4E4-1A902059E876Q34588653-F354F72D-257E-43FB-B3FB-3518D32794FFQ35886877-2FA75CEE-4152-494F-AC89-2114B5F1F5FEQ35952887-37C87B93-A74B-4D9C-98F2-4198059F5376Q35955196-82482E83-F0DB-41AD-8587-04A60EA18EA1Q36392151-76566934-ACE8-4DB3-BB4D-9F10EC063DB0Q36421331-071DDB5A-A1CA-47E5-941B-FFF83AD058B8Q36667455-271FBF43-A2BE-4C75-8AE0-731A01B969B4Q37025333-C48FD998-D160-4C5B-A085-79AA7210290AQ37122031-6B1A5427-DEE9-4AF3-8A01-322C1E9D2392Q37166395-48058DEA-F05C-4C0C-82CE-858E7E336F36Q37205539-87FD5078-126A-490D-B62B-DDEF91D78C2CQ37220420-FA4C2A66-6ED0-4657-980A-0C29C080C659Q37719054-4723ED1F-1CDA-4D9A-A6C5-F19137B949FAQ41622102-B7425050-7210-4D2B-808D-27990843DE76Q41871901-5A13F9FE-4AEA-4F82-B63E-E965AAB7B32EQ41999245-0154B587-3874-468D-A656-2C1BDCE5AF85Q55183269-4C25FAE9-2BBA-4D86-8541-1A91E8C37157Q58798774-CABB779D-002C-4DEF-B1A2-0236C391ED35
P2860
Polycomb group proteins in cell cycle progression and cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Polycomb group proteins in cell cycle progression and cancer.
@en
Polycomb group proteins in cell cycle progression and cancer.
@nl
type
label
Polycomb group proteins in cell cycle progression and cancer.
@en
Polycomb group proteins in cell cycle progression and cancer.
@nl
prefLabel
Polycomb group proteins in cell cycle progression and cancer.
@en
Polycomb group proteins in cell cycle progression and cancer.
@nl
P50
P1433
P1476
Polycomb group proteins in cell cycle progression and cancer
@en
P2093
Adrian P Bracken
P304
P577
2004-04-01T00:00:00Z